Donor Modified Immune Cells

· TolerogenixX GmbH

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Donor Modified Immune Cells, covering 2025-04-11 to 2025-04-11. Get the full timeline:

Most recent: Clinical Trial Update: Clinical Trial With Donor Modified Immune Cells in Living Donor Kidney Transplantation [Phase 2]